PATH | VRL
Menu

Find resources

Total results with these characteristics: 90

Disease: Polio

Page 2 of 5
Global Post-Eradication IPV Supply and Demand Assessment: Integrated Findings

This report summarizes the findings from a global post-eradication inactivated polio vaccine (IPV) supply and demand assessment conducted from 2007 to 2008. The goal of the study was to inform ongoing IPV discussions and potential policy development …

Author: Oliver Wyman, Inc.

Publication date: 2009

Health Topics: Poliomyelitis

This web page provides information about poliomyelitis including general and technical information, data on the disease, and information about the World Health Organization's work to eradicate it.

Author: World Health Organization

A HealthTech Historical Profile: Vaccine Vial Monitors

A major problem in immunization programs throughout the world has been the challenge of monitoring and managing the temperature of vaccines as they travel through the distribution chain to the destinations where they are used. This report provides …

Author: PATH, US Agency for International Development

Publication date: 2005

Hexavalent IPV-Based Combination Vaccines for Public-Sector Markets of Low-Resource Countries

This article, published in Human Vaccines & Immunotherapeutics, evaluates potential hexavalent vaccine candidates containing inactivated polio vaccine (IPV) that could provide reliable, low-cost, and continuous immunization to sustain polio …

Author: Mahmood K, Pelkowski S, Atherly D, Sitrin R, Donnelly JJ

Publication date: 2013

How Can Data Help Fight Disease?

This animated video explains the important role that data plays in fighting polio worldwide. Data about cases of polio, the size of an outbreak and the population affected, and information about vaccination programs can be collected and shared …

Author: Bill & Melinda Gates Foundation

Publication date: 2016

Immune Responses and Protection in Children in Developing Countries Induced by Oral Vaccines

Oral mucosal vaccines have great promise for generating protective immunity against intestinal infections for the benefit of large numbers of people especially young children. However, these vaccines are not equally immunogenic nor protective in …

Author: Qadri F, Bhuiyan TR, Sack DA, Svennerholm A-M

Publication date: 2013

Immunization

This site offers information on vaccine and immunization programs at the American Academy of Pediatrics and includes video and text resources for parents. Resources include frequently asked questions for families, immunization information for …

Author: American Academy of Pediatrics

Immunize Canada

This partnership of nongovernmental, professional, health, consumer, government, and private-sector organizations aims to promote the understanding and use of vaccines recommended by Canada's National Advisory Committee on Immunization. Its goal is …

Author: Immunize Canada

The Immunogenicity of Fractional Intradermal Doses of the Inactivated Poliovirus Vaccine is Associated With the Size of the Intradermal Fluid Bleb

In response to the global shortage of inactivated poliovirus vaccine (IPV), the World Health Organization now recommends the use of fractional (one-fifth) intradermal doses of IPV (ID fIPV), both in campaigns and routine immunization schedules. This …

Author: Bibby J, Saidu Y, Umesi A, et al.

Publication date: 2017

The Immunological Basis for Immunization Series

This web page provides links to individual disease/vaccine-specific modules that are intended to give immunization managers and vaccination professionals a brief and easy-to-understand overview of the scientific basis of vaccination, as well as the …

Author: World Health Organization

Improving the Affordability of Inactivated Poliovirus Vaccines (IPV) for Use in Low- and Middle-Income Countries: An Economic Analysis of Strategies to Reduce the Cost of Routine IPV Immunization

This report presents results from an economic model that calculates the costs involved in delivering IPV vaccine in Indian immunization clinics according to three strategies: (1) intradermal delivery of reduced volumes of vaccine per dose, (2) use …

Author: PATH, Working in Tandem, Ltd.

Publication date: 2010

Inactivated Polio Vaccine Development for Technology Transfer Using Attenuated Sabin Poliovirus Strains to Shift From Salk-IPV to Sabin-IPV

Even after polio eradication, countries will need to continue immunization against poliomyelitis to prevent the risk of a global outbreak due to accidental or deliberate re-introduction of the virus. Following the demonstration of a …

Author: Bakker WA, Thomassen YE, van't Oever AG, et al.

Publication date: 2011

Indian Academy of Pediatrics Advisory Committee on Vaccines and Immunization Practices

This website from the Indian Academy of Pediatrics provides up-to-date information on vaccination for the general public and heath care professionals. It provides a range of resources including information about the latest recommendations by the …

Author: Indian Academy of Pediatrics Advisory Committee on Vaccines and Immunization Practices

Intradermal Delivery of Vaccines: A Review of the Literature and the Potential for Development for Use in Low- and Middle-Income Countries

The purpose of this report is: (1) to summarize the clinical evidence supporting the intradermal route for vaccine administration and the devices being developed for this purpose; (2) to determine whether intradermal delivery broadly holds promise …

Author: PATH

Publication date: 2009

IPV Introduction and the Polio Endgame

This web page provides summaries and links to new communications materials to support the introduction of inactivated polio vaccine (IPV) and to help communicate the need for IPV introduction. The resources include case studies on IPV introduction …

Author: International Vaccine Access Center

IPV Introduction, OPV Withdrawal and Routine Immunization Strengthening

This web page contains the rationale for and resources related to the introduction of inactivated polio vaccine (IPV), withdrawal of oral polio vaccine (OPV), and routine immunization strengthening. It provides five in-depth modules covering issues …

Author: World Health Organization

Landscape Analysis: Trends in Vaccine Availability and Novel Vaccine Delivery Technologies: 2008–2025

This landscape analysis identifies trends in the availability of vaccines and novel vaccine delivery technologies that are and will be of relevance to low- and middle-income countries from the present through 2025.

Author: PATH, World Health Organization

Publication date: 2008

Maternal Immunization: Country Priorities and Market Requirements

Maternal immunization is an approach of vaccinating during pregnancy to enhance immunity for both mother and baby. This report provides insight into country priorities for maternal immunization and characterizes the market for adult immunizations in …

Author: PATH

Publication date: 2015

Meeting of the Strategic Advisory Group of Experts on Immunization, October 2014 – Conclusions and Recommendations

This article, published in the Weekly Epidemiological Record, summarizes the conclusions and recommendations of the Strategic Advisory Group of Experts on Immunization (SAGE). The article includes sections with SAGE recommendations regarding …

Author: World Health Organization

Publication date: 2014

Moving the Needle

This quarterly e-newsletter provides updates from PATH’s Center for Vaccine Innovation and Access on its vaccine development efforts, as well as related supporting work, such as developing human challenge models, building capacity of …

Author: PATH

Page 2 of 5